ICPT
These are the top analyst upgrades, downgrades, and initiations seen before markets opened on Friday, July 14, 2023.
Published:
Friday's top analyst upgrades and downgrades included Citizens Financial, Eaton, Freeport-McMoRan, General Mills, Graphic Packaging, Micron Technology, Mosaic, Netflix, Pfizer, Roku, Ross Stores and...
Published:
Tuesday's top analyst upgrades and downgrades included Altria, American International Group, Datadog, DraftKings, Emerson Electric, Marriott International, NortonLifeLock, Opendoor Technologies,...
Published:
Tuesday afternoon's top analyst upgrades and downgrades included Alcoa, American Tower, Las Vegas Sands, Paychex, US Steel and more.
Published:
Last Updated:
Friday's top analyst upgrades and downgrades included Duke Energy, Macy's, Mosaic, Nvidia, SAP, ServiceNow, Shopify and Workday.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Nielsen, Nordstrom, PayPal, StoneCo and more.
Published:
24/7 Wall St. looks at some big analyst calls that we have seen so far on Tuesday, including Exxon, Kohl’s, MGM, Spotify and more.
Published:
Friday's top analyst upgrades and downgrades included Airbnb, Discovery, DoorDash, Hewlett Packard Enterprise, Intel, Snap and Spotify.
Published:
Monday's top analyst upgrades and downgrades included Ally Financial, Callaway Golf, Infinera, Lithia Motors, Microsoft, Nike, SolarWinds, Tapestry and Walmart.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
Published:
Last Updated:
Tuesday's top analyst upgrades and downgrades included ANGI Homeservices, Carnival, Chegg, Clorox, Crocs, Dish Network, Etsy, Intercept Pharmaceuticals, Micron Technology, Okta, Seattle Genetics,...
Published:
Intercept Pharmaceuticals stock was crushed early on Monday after the firm received an update from the FDA in regards to its treatment of fibrosis due to nonalcoholoic steatohepatitis.
Published:
These five top biotech companies range from a large-cap leader with a potential coronavirus treatment to a small-cap company with massive upside potential.
Published:
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk...
Published:
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Published: